There are questions of hiring of staff, of leadership buy-in, of funding that all come into play when you are talking of how to scale a model beyond a single site, said Mavis Asiedu-Frimpong, director for national initiatives at the Camden Coalition of Healthcare Providers.
There are questions of hiring of staff, of leadership buy-in, of funding that all come into play when you are talking of how to scale a model beyond a single site, said Mavis Asiedu-Frimpong, director for national initiatives at the Camden Coalition of Healthcare Providers.
Transcript
What are the challenges when a model of care is tested and it works, but now it needs to be scaled?
That’s a great question. So, there are a couple of ways in which that comes into play, and I will mention that one of the projects that the National Center is working on is focused exactly on that question. And so, we are working with health quality partners and the Peterson Center on Healthcare to really understand the science behind replication. And some of the things that we’re seeing are first the question of fidelity.
So, what are the real components of a model that must stay in place no matter where it is implemented? Then there are questions also of the local context and what part local context actually plays in the success of how a model is actually implemented in different places, as well.
And then there’s also the nuts and bolts of readiness. How do you know that a community is really ready to implement something that has been implemented elsewhere? So, there are questions of hiring of staff, of leadership buy-in, of funding that all come into play when you are talking of how to scale a model beyond a single site.
And that’s what we’re doing in our Peterson [Health Quality Partners] Project. And we are really excited to share that learning with the field because it comes up over and over again and we really feel well positioned to support the answer to that question.
Do questions around funding come up, and how do those discussions go?
Yeah, it’s one of the critical questions that the project is going to be looking at. And so phase 2 is going to start next year, and in phase 2 we are actually going to be selecting sites where the model that we are testing is going to be implemented. And so the questions of funding come up there.
So, the readiness is very much connected to the funding. How do you actually make sure that you have the resources, not just financial resources but the staff capacity to actually implement a model successfully?
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More